A Study of Synthetic Human Secretin (ChiRhoStim®) Administered Intravenously to Stimulate Exocrine Pancreas Fluid Secretion for Collection Via Endoscope and Laboratory Analysis of DNA Markers

Clinical trial NCT01087801 · COMPLETED

Trial details

NCT number: NCT01087801
Sponsor: ChiRhoClin, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Disease

Start date: 2007-10-01
Primary completion: 2009-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.